{
    "nctId": "NCT05462457",
    "briefTitle": "TAD in Primary Breast Cancer With Initially \u2265 3 Suspicious Lymph Nodes",
    "officialTitle": "Prospective, Multicentric Registry Study Evaluating the False-negative Rate of Targeted Axillary Dissection (TAD) in Primary Breast Cancer With Initially \u2265 3 Suspicious Lymph Nodes Under Neoadjuvant Systemic Therapy (SenTa 2)",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Node-positive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "False-negative rate (FNR) of TAD in patients with ycN0 status",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* signed informed consent form\n* female/male patient aged \u2265 18 years\n* clinical (c) tumor stage T1-4c, bilateral breast cancer and multifocal tumor allowed\n* invasive breast cancer confirmed by core biopsy\n* clinically node positive (cN+) (by means of axillary ultrasound or other imaging methods) with \u2265 3 clinically suspicious lymph nodes\n* biopsy-proven axillary lymph node involvement\n* marking (e.g. with a clip, magnetic seed, carbon suspension) of the clinically suspicious lymph node(s) before the start of NST\n* without distant metastases\n* indication for NST including chemotherapy\n* TAD + ALND planned\n* at least 7 lymph nodes (TAD + ALND) planned for histological analysis\n\nExclusion Criteria:\n\n* cN0 or cN+ with \u2264 2 clinically suspicious lymph nodes\n* patients without indication for NST or NST \\< 12 weeks\n* NST without chemotherapy\n* adjuvant/ neoadjuvant therapy already started prior to inclusion in the study\n* patients for whom only ALND is planned\n* ycN+ (by means of axillary ultrasound or other imaging methods)\n* recurrent breast cancer\n* larger surgery of the breast (starting from quadrant resection) or the axilla prior to the study\n* previous radiotherapy of the breast or axilla\n* inflammatory breast cancer\n* extramammary breast cancer\n* pregnant women\n* not able to undergo surgery\n* inability to understand the purpose of the clinical study or to comply with study conditions",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}